- Illumina, Life Technologies announce one-day sequencers
Within hours of each other, Illumina and Life Technologies announced they will release gene-sequencing machines that can decode a person's genome in one day. Illumina's HiSeq 2500 will be available in the second half of the year, and Life Technologies is taking orders for its Ion Proton technology. Forbes (1/10), Bloomberg (1/10)        - Genentech-Xenon deal involves pain drugs and companion tests
Roche Holding unit Genentech and Xenon Pharmaceuticals agreed to co-develop pain treatments paired with diagnostic tests. The alliance entitles Xenon to as much as $646 million for milestones, plus royalties. Genentech has exclusive rights to the drugs and nonexclusive rights to any companion diagnostic. PharmaTimes (U.K.) (1/10) - Maternal cord blood cells can reduce risk of leukemia relapse
 Matching cord blood donors and recipients based on certain maternal immune cells can lessen the chance of a leukemia relapse, according to a study published in the journal Proceedings of the National Academy of Sciences. Pregnant women develop B and T cell immune responses to the paternal human leukocyte antigens in the fetus, and it is this immunity that gives maternal cord blood cells "a potent graft-versus-leukemia effect," the researchers said. MedPage Today (free registration) (1/9) - China halts stem cell therapies, trials
China's Ministry of Health, together with the State Food and Drug Administration, has issued an order preventing hospitals and clinics from offering unapproved stem cell treatments, which attract both local and foreign patients. Applications for stem cell projects will also be rejected by the ministry until July as part of the government's one-year campaign to improve industry regulations. Reuters (1/10)  | The telephony market is making a lot of smart people make poor choices. Take a minute to read the latest VoIP News and ground your opinion in hard-bitten analysis. In this complimentary guide, we chart the future of IP-convergence, mobility, IPv6, and much more. Get the VoIP News here. |
 - Conn. offers loans, grants for new Jackson Lab branch
Connecticut offered $99 million in grants and a $192 million forgivable construction loan for the Jackson Laboratory Genomic Medicine center to be built on the University of Connecticut Health Center campus. Public-private agency Connecticut Innovations will receive a portion of royalty proceeds from intellectual property developed at the lab, and state residents will be given hiring preference for the 300 jobs that will be created over the next 10 years. Reuters (1/5)  | Principles of Checkweighing - Building an Effective Program
This essential guide is an invaluable resource of checkweighing information and a definitive reference providing an insight into all aspects of checkweighing from basic principles to implementation of a comprehensive program. Request your free copy now! |
 | Drug Development Basic Training |  |  | | - Finox Biotech's Selz on the need for product differentiation
In this final podcast of three, Anjan Selz, co-founder and CEO of Finox Biotech, denounces the destructive nature of focusing only on price in the biosimilar space and says the ability to differentiate and improve should drive development. Differentiation can come in many forms, including new formulations, delivery devices and even packaging. In the case of a "lifestyle" like Afolia, the emphasis is on improved consumer experience. Selz concludes by offering excellent insight into project management and some of the secrets behind moving so quickly through development. Listen here. |  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| Food & Agriculture | | | | - Dow, Fraunhofer Institute unite for biotech crop research
Dow AgroSciences and German research company Fraunhofer Institute for Molecular Ecology agreed to conduct joint research on crop improvement using biotechnology. The deal will provide Dow AgroSciences' customers with better products, according to Daniel Kittle of the company's research and development department. Farm Industry News (1/10) | Industrial & Environmental | | | | - AEC's Coleman: Cellulosic-ethanol sector is making strides
Progress is being made in the commercialization of cellulosic ethanol, despite moves to lower its 2011 and 2012 Renewable Fuel Standard targets because of a lack of availability, according to Advanced Ethanol Council Executive Director Brooke Coleman. "In a very difficult financial and policy environment, the first wave of commercial advanced ethanol production facilities are under construction in a number of states across the country," Coleman said. DomesticFuel.com (1/10) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | A good swordsman is not given to quarrel."
|
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Tuesday, January 10, 2012
- Monday, January 09, 2012
- Friday, January 06, 2012
- Thursday, January 05, 2012
- Wednesday, January 04, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment